Primary Site >> Colorectal Cancer

Gene >> HLA-C

  • 1986
  • 1987
  • 1988
  • 1989
  • 1991
  • 1992
  • 1994
  • 1995
  • 1997
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2008
  • 2012
  • 2014
  • 2015
  • 2017
Ref: Expression of MHC class II products on human colorectal cancer. An immunohistological and flow cytometric study.
PMID: 3469276
 Ref: Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease.
PMID: 3425689
 Ref: Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.
PMID: 2839218
 Ref: MHC status of primary human colorectal carcinoma: biological significance and implications for host immune recognition.
PMID: 2648714
 Ref: MHC expression on human tumors--its relevance for local tumor growth and metastasis.
PMID: 1912516
 Ref: The role of surface HLA-A,B,C molecules in tumour immunity.
PMID: 1423320
 Ref: Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells. Differential effect on HLA-A, -B and -C loci.
PMID: 8196671
 Ref: [Update on the use of interferons in clinical practice].
PMID: 7586995
 Ref: Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells.
PMID: 9126997
Ref: Association of the TNFa2 microsatellite allele with the presence of colorectal cancer.
PMID: 9243755
 Ref: Current concepts in immunotherapy for the treatment of colorectal cancer.
PMID: 12018689
Ref: Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.
PMID: 12421958
Ref: Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients.
PMID: 12480922
 Ref: Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
PMID: 12694570
 Ref: Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling.
PMID: 15004565
 Ref: Natural killer cells infiltrating colorectal cancer and MHC class I expression.
PMID: 15607811
 Ref: Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
PMID: 16609036
 Ref: Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.
PMID: 18307280
 Ref: The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?
PMID: 22426959
 Ref: Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy.
PMID: 24218514
Ref: Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases.
PMID: 24894090
Ref: MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.
PMID: 25297629
Ref: Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer.
PMID: 25340937
 Ref: Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy.
PMID: 25853550
 Ref: Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
PMID: 28287848